Most tau PET studies conducted to date are single-center studies with insufficient sample sizes for providing reliable prevalence estimates of tau PET positivity, especially when these samples are stratified to explore the effects of individual risk factors for AD-type dementia such as age, sex and APOE genotype. Here, MAPT is linked to dementia.